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Policy Points:  
 
 While most scholarship regarding the US Public Health Service’s STD 
experiments in Guatemala during the 1940s has focused on the intentional 
exposure experiments, secondary research was also conducted on biospecimens 
collected from these subjects.  
 These biospecimen experiments continued after the Guatemala grant ended, and 
the specimens were used in conjunction with those from the Tuskegee syphilis 
experiments for ongoing research. 
 We argue there should be a public accounting of whether there are still 
biospecimens from Guatemala and Tuskegee held in US government 
biorepositories today, and if such specimens exist, they should be retired from 
research archives because they were collected unethically as understood at the 
time.   
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Context: The US Public Health Service’s Guatemala STD experiments (1946-1948) included 
intentional exposure to pathogens and testing of postexposure prophylaxis methods for 
syphilis, gonorrhea, and chancroid in over 1,300 soldiers, sex workers, prison inmates, and 
psychiatric patients. Though the experiments had officially ended, the biospecimens collected 
from these subjects continued to be used for research at least into the 1950s.  
 
Methods: We analyzed historical documents—including clinical and laboratory records, 
correspondence, final reports, and medical records—for information relevant to these 
biospecimen experiments from the US National Archives. In addition, we researched material 
from past governmental investigations into the Guatemala STD experiments, including those 
of the US Presidential Commission for the Study of Bioethical Issues and the Guatemalan  
Comisión Presidencial para el Esclarecimento de los Experimentos Practicados con Humanos 
en Guatemala. 
 
Findings: Identified spinal fluid, blood specimens, and tissue collected during the Guatemala 
diagnostic methodology and intentional exposure experiments were subsequently distributed 
to laboratories throughout the United States for use in ongoing research until at least 1957. 
Five psychiatric patient subjects involved in the biospecimen experiments died soon after 
exposure to STDs. The same US government researchers working with the Guatemala 
biospecimens after the exposure experiments ended were also working with specimens taken 
from the Tuskegee syphilis study. 
 
Conclusions: There should be a complete public accounting of whether biospecimens from 
the Guatemala and Tuskegee experiments are held in US government biorepositories today. If 
they still exist, these specimens should be retired from such biorepositories and their future 
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disposition determined by stakeholders, including representatives from the communities from 
which they were derived. 
 
Keywords: research ethics, Guatemala STD experiments, Tuskegee syphilis experiments, 
Common Rule 
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On January 7, 1957, Dr. John C. Cutler, then a senior surgeon in the United States 
Public Health Service’s (PHS) Venereal Disease Division, requested 9 tissue samples from 
his colleague Dr. Llewellyn Lee Ashburn, chief of the section on pathology and anatomy at 
the National Institutes of Health (NIH). Cutler described the material as ―autopsy and biopsy 
material‖ connected to his ―former research project.‖1 Cutler listed all of the donors by full 
name and subject number and identified whether the sample was from the subject’s urethra, 
skin, or cervix. He asked that the biospecimens be sent to Dr. James D. Thayer at the 
University of North Carolina, Chapel Hill’s (UNC) Venereal Disease Experimental 
Laboratory (VDEL) for use in his gonorrhea research.
1
 (See Table 1 for a list of the key 
players and their affiliations.) 
Cutler would later become notorious for his involvement in the PHS STD experiments 
conducted in Guatemala from 1946 to 1948, which drew media attention and public ire in 
2010 when the records were disclosed.
2
 Ashburn would have been familiar with this research, 
as he was in Guatemala conducting his own research on river blindness at the same time as 
Cutler.
3
 The intentional exposure experiments were initially designed to test postexposure 
prophylaxis for syphilis, gonorrhea, and chancroid. These experiments ultimately involved 
exposing more than 1,300 soldiers, sex workers, prison inmates, and psychiatric patients 
without their consent or sometimes even knowledge. PHS and Guatemalan researchers used 
injections and other invasive interventions to intentionally expose these subjects to infectious 
disease; only half of the subjects received any subsequent treatment for potential infection.
4
  
Thayer, the recipient of the samples in 1957, had previously worked at the Venereal 
Disease Research Laboratory (VDRL) in Staten Island with Cutler and his supervisors.
5
 The 
samples Thayer requested were collected during the Guatemala STD experiments from 4 men 
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and 4 women—all patients from the Asilo de Alienados, a psychiatric hospital in Guatemala 
City.
6
 Cutler sent these tissue samples from Guatemala to the NIH. He noted in 1956 that 
they had been ―up to eight years in formaldehyde,‖ indicating they were collected before he 
left Guatemala in 1948.
7
  
The Guatemala intentional exposure experiments have already been scrutinized in 
several publications. Analysis of those experiments by historian Susan Reverby resulted in 
government-led investigations by the US Centers for Disease Control and Prevention (CDC),
8
 
President Obama’s Presidential Commission for the Study of Bioethical Issues (Bioethics 
Commission),
4 
and the government of Guatemala.
9-11
 Other related scholarship has explored 
how the intentional exposure experiments were approved,
12
 critiqued the Bioethics 
Commission’s report,13 reviewed the history of the NIH’s regulatory structure,14 called for 
compensation for victims,
15
 and evaluated the legacy of associated physicians.
16
 But there 
were actually 3 types of experiments being conducted by US government officials and their 
Guatemalan counterparts during this time period:  
1. Diagnostic methodology experiments: Taking blood and spinal fluid to test the 
sensitivity and specificity of syphilis diagnostic methodologies.  
2. Intentional exposure experiments: Intentionally exposing subjects to syphilis, 
gonorrhea, and/or chancroid as part of a larger protocol to test the effectiveness of 
prophylaxis and treatment methods.  
3. Biospecimen experiments: Collecting and experimenting with identified spinal 
fluid, blood, and tissue specimens from research subjects in the diagnostic 
methodology and intentional exposure experiments, even after the Guatemala 
STD experiment grant funding ended. 
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The Bioethics Commission discussed the diagnostic methodology and intentional 
exposure experiments in its 2011 report, but only briefly acknowledged the biospecimen 
experiments.
4(p83)
 This article is the first to explore how the subjects from the diagnostic 
methodology and intentional exposure experiments played one last role in the Guatemala 
STD experiments—as unknowing secondary research subjects in blood, tissue, and/or spinal 
fluid research. The biospecimens collected from the Guatemalan subjects during both the 
diagnostic methodology and intentional exposure experiments were subsequently distributed 
to laboratories throughout the United States for use in this ongoing research.
7,17
  
The current disposition of the Guatemala biospecimens is particularly significant, as 
in January 2017, 16 US federal departments and agencies released revisions to the current US 
human subjects protection research regulations.
18
 This was the first major revision of 
regulations initially conceived in the 1970s as a response to federally funded research 
scandals, most notably the Tuskegee syphilis experiments (in which PHS researchers 
observed poor black sharecroppers with syphilis in Macon County, Alabama, for decades and 
prevented them from receiving treatment).
19
 The most significant controversy surrounding 
the revisions to the research regulations involved informed consent to research with human 
specimens.
20
 
Here we review the relevance of the Guatemala intentional exposure and diagnostic 
methodology experiments to the subjects who later became part of the biospecimen 
experiments, secondary research which extended at least through 1957. The US government 
researchers who conducted those experiments in Guatemala were the leaders of the venereal 
disease research movement for the first two-thirds of the twentieth century; many of the same 
men who approved the intentional exposure experiments as members of the NIH Syphilis 
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Study Section later benefited from that approval by engaging in the biospecimen 
experiments,
12
 and some of those scientists were also simultaneously working with samples 
taken from the Tuskegee syphilis study.  
While the Guatemala biospecimen experiments are historically important in their own 
right, we believe they can also inform current policy discussions concerning research 
involving biospecimens. Our ethical and regulatory entities still struggle with the appropriate 
normative framework with which to approach the research use of such specimens—
particularly those that have been obtained through improper means. Here we argue that there 
should be a complete public accounting of whether biospecimens from the Guatemala and 
Tuskegee experiments are held in US government biorepositories today. If they still exist, 
these specimens should be retired from such biorepositories and their future disposition 
determined by stakeholders, including representatives from the communities from which they 
were derived. 
 
The Guatemala STD Experiments 
Intentional Exposure Experiments 
The original research grant for the ―Guatemala study dealing with the experimental 
transmission of syphilis to human volunteers and improved methods of prophylaxis‖21 
supported intentional exposure experiments that ran from February 1947 through October 
1948.
4(p127)
 During this time period, Cutler collected from psychiatric patients the 
biospecimens that Thayer would later request. It is possible to review the de-identified 
research records of these subjects via the Bioethics Commission’s ―Guatemala Subject Data 
Spreadsheet,‖6 as well as from material published by the Guatemalan government’s Comisión 
Presidencial para el Esclarecimento de los Experimentos Practicados con Humanos en 
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Guatemala.
9-11
 Through these records we know that these subjects endured some of the most 
severe experimental exposure interventions documented. 
Subjects who later were involved in the Guatemala biospecimen experiments were 
exposed to syphilis, gonorrhea, or chancroid during the intentional exposure experiments; 2 
of the subjects were exposed to more than one STD (Table 2). Methods of exposure included 
inserting a toothpick coated in gonorrheal pus (taken from another patient) deep into the 
urethra or into the eyes. Syphilitic emulsion was injected into subjects’ arms (Figure 1) or 
rubbed into their intentionally abraded genitals. Only 2 of the 8 subjects have any record of 
being treated for these exposures. Five of the subjects died during the experiments and were 
given autopsies by staff at the psychiatric hospital. No information regarding death or autopsy 
results is available for 2 patients. One patient was discharged from the institution, with the 
record indicating that she had been ―freed‖ (see Table 2). 
Of the 5 patients whose deaths were recorded, all died proximate to the time in which 
they were involved in the intentional exposure experiments (see Table 2). The Bioethics 
Commission reported 83 deaths of subjects during the Guatemala STD experiments, but 
found that ―the exact relationship between the experimental procedures and the subject deaths 
is unclear.‖ 4(p42) Cutler claimed in his later report that this ―steady loss of patients by death‖ 
was primarily due to high rates of tuberculosis and the fact that ―acute and chronically ill 
patients were used‖ (Figure 2).4(p42) 
 
Diagnostic Methodology Experiments 
In addition to biospecimens that Cutler collected himself during the intentional exposure 
experiments, specimens were also mailed to the United States by additional PHS and 
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Guatemalan researchers.
4(p83)
 For example, Genevieve Stout, a PHS microbiologist and 
serologist who worked for VDRL director John F. Mahoney, moved from the VDRL to act as 
the director of the Guatemala laboratory, where she conducted diagnostic methodology 
experiments of her own.
4(p82), 23-27
 The VDRL in Chamblee, Georgia, cosponsored this 
research and served as a control laboratory for some of the work.
28
  
In addition to Stout, the PHS continued to support several local Guatemalan staff after 
the Guatemala STD grant ended. Cutler wrote that he and Dr. Sacha Levitan (also a PHS 
senior surgeon and the ―assistant director‖ of the intentional exposure experiments) felt that 
continued observation of the Guatemala intentional exposure subjects was critical.
29
 Cutler 
recommended Dr. Juan Funes (his former PHS fellow and chief of the VD Section of the 
Guatemalan Ministry of Public Health), as well as Dr. Carlos Salvado (the director of the 
Guatemalan psychiatric hospital), to supervise the ongoing research.
29
 These doctors and 
several staff were offered part-time salaries from the PHS Division of Venereal Disease for 
―post-treatment‖ observation of the subjects, and additional funds were set aside to pay for 
cigarettes to reward subjects and to support autopsies.
29-30
 Medical records were also updated 
and provided to Cutler, who kept them in a personal record collection.
31
 Funding was 
specifically allocated for preparation and shipment of biospecimens to the Staten Island 
VDRL.
30
 Payments from the Division of Venereal Diseases to the Guatemalan physicians 
ended in May/June 1950,
32
 although they shipped biospecimens to the United States until at 
least 1953.
17 
 While the PHS employment contract for Funes indicated that the ongoing research 
would be with patients—including orphans, schoolchildren, prisoners, indigenous 
communities, and those released from the psychiatric institution
30—the single available 
contemporaneous report is actually a record of diagnostic methodology experiments 
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involving 243 blood draws and 170 lumbar punctures collected exclusively from 248 
institutionalized psychiatric patients.
4(p83n628) 
While all of these subjects were described as 
―post-treatment,‖ the diagnostic records provided with the samples demonstrate that 30 
patients still tested positive for syphilis by at least one diagnostic metric (Online Appendix).
17
 
There is no record that these patients received any additional treatment. 
 
Biospecimen Experiments 
Biospecimens from people with STDs, such as the ones sent from Guatemala, were a highly 
valued commodity during Cutler’s time in Guatemala and the decade thereafter. Serologic 
testing of blood was the backbone of syphilis diagnosis and control, but—as in Guatemala—
researchers were still studying appropriate diagnostic methodologies into the 1950s and 
beyond. 
 In a 1995 article, Benjamin Roy argued that the primary goal of the Tuskegee syphilis 
experiments had not been, in fact, to observe the natural progression of syphilis, as the 
clinical publications claimed—but rather to develop serological testing for the US 
commercial market.
33
 As a result of significant increases in federal funding for syphilis 
eradication from the 1930s through the 1950s, the market for STD testing grew into a 
lucrative business during the years that encompassed the Tuskegee and Guatemala 
experiments, as the number of people being tested rose rapidly.
33
 Laws requiring syphilis 
testing for ―marriage certificates, newborns, military recruits, industrial physical 
examinations, and admissions to hospitals‖ ensured steady work for laboratories.33(p64) To 
support the diagnostic research necessary to do this kind of testing, Tuskegee syphilis 
experiment researchers sent biopsy material, medical records, X-rays, and autopsy 
spinal/brain samples to researchers at the NIH and universities like Johns Hopkins and UNC–
Chapel Hill (where Thayer worked using PHS funds).
7,19(p148-149),34
 In 1970, James Lucas, 
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assistant chief of the venereal disease branch of PHS, claimed that the only scientific benefit 
of the Tuskegee syphilis experiments was the development of STD diagnostic 
methodologies.
19(p202)
 
 Stout, Funes, and Cutler also sent several different kinds of biospecimens from the 
Guatemala experiments to the same biorepositories that housed the Tuskegee materials. But, 
unlike the Tuskegee syphilis experiments which resulted in many publications (one of which 
included Cutler as a coauthor
 35
), data from the Guatemala intentional exposure experiments 
were never published.
4(p86)
 We also found no evidence that work from the biospecimen 
experiments was described in peer-reviewed publications.  
One of the few extant records confirms that Funes, the Guatemalan physician paid by 
the US government to conduct diagnostic methodology experiments, mailed blood and spinal 
fluid specimens to the Chamblee, Georgia, VDRL in 1953. There, the biospecimens were 
received by VDRL associate director Dr. W.F. Edmundson, assistant director Ad Harris, and 
Cutler.
17
 VDRL director Dr. Sidney Olansky—who at the time was the director of the 
Tuskegee syphilis experiments
19—was also listed on the Guatemala biospecimen manifest.17 
Edmundson was simultaneously working on ―serologic reactions in untreated syphilitic male 
Negroes‖ to determine ―specific morbidity and mortality of latent syphilis in a group of 
untreated male Negros‖ in Macon County, Alabama (ie, Tuskegee).36 In another study, 
Edmundson, Olansky, Harris, Cutler, and Dr. Harold J. Magnuson—the director of the UNC 
VDEL who recruited Thayer—coauthored a paper on a protocol of US prisoners who were 
experimentally exposed to syphilis—evidence of the close working relationship of these 
researchers and overlapping use of STD specimen collections.
37
 
In October 1956, 3 years after the biospecimens were sent from Guatemala, Thayer 
met with his former VDRL colleague Cutler at a scientific conference in Washington, DC.
38-
39
 At that meeting, Cutler informed Thayer that biospecimens obtained from 9 subjects in 
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Guatemala and brought back to the United States were available for research.
7
 Upon return to 
the UNC VDEL in 1957, Thayer requested access via letter to these biospecimens for his 
―studies in gonorrhea related to the possible intra-cellular location of the gonoccus [sic], the 
durcrey bacillus and the treponema pallidum as affecting response to therapy.‖1 Ashburn 
responded to Thayer’s request by providing 8 biospecimens stored in paraffin (one specimen 
had been misplaced) from the NIH biorepository, in addition to related medical records to 
help ―put the single tissue in perspective.‖1,40 It is unclear from Thayer’s UNC VDEL records 
whether he ever used these Guatemalan tissue samples for his own experiments.  
 
Policy Implications for Contemporary Biospecimen Research  
Just as it was in Cutler’s time, use of biospecimens and related data remains a critical 
component of current medical research. Programs such as the ―Precision Medicine Initiative,‖ 
which promise individually tailored therapies, require vast amounts of data and health 
information from hundreds of thousands of people in order to advance medical science.
41
 The 
banking of biospecimens and data for future research has become almost as important as 
conventional clinical trials and provides a springboard for thousands of secondary research 
protocols.
20
 Despite their value, however, our ethical and regulatory response to the uses of 
human biospecimens has struggled to keep up with the public’s normative expectations. 
Debate Over Use of Cadavers, Biospecimens, and Unethically Obtained Data 
Infamous crimes committed by the Nazis under the guise of medical research provide another 
classic example of egregious experimentation clearly in violation of research ethics standards 
at the time.
42
 The actions of the physician researchers involved were publicly condemned in 
the subsequent ―Nazi Doctors Trial,‖ in which 16 defendants were found guilty of murder 
and torture and 7 were sentenced to death.
42
 Although the opening statement for the 
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prosecution argued at trial that the Nazi experiments ―revealed nothing which civilized 
medicine can use,‖43 cadavers, biospecimens, and data from the Nazi era have in fact been 
integrated into ongoing medical education and scientific research for decades.
44
 For example, 
Tubingen Medical School received 1,077 cadavers from a Holocaust execution site and, 
along with other West German medical schools, used skeletons and biospecimens from 
Holocaust victims in anatomy classes until the 1990s.
45
 However, after public outcry in Israel 
and elsewhere over the continued use of these biospecimens and cadavers, ―[t]he pendulum 
swung from retention to disposal,‖ and many anatomical specimens were given a religious 
burial.
44-45
 
It is worth clarifying the distinction between using artifacts and data to educate people 
about past atrocities, to honor the victims, and to attempt to prevent similar occurrences 
versus using them for general medical or science education or ongoing research purposes. On 
one end of the spectrum, the use of unethically obtained Holocaust cadavers or biospecimens 
for ongoing research purposes is inappropriate because it uses the victims as a means to 
scientific ends and can even be considered a re-victimization.
46
 The use of Nazi victim 
cadavers and biospecimens by West German medical schools for general anatomy education 
is inappropriate, because by treating them similarly to those obtained via legitimate means 
(eg, donation after natural death), it fails to acknowledge in any way the indignity, affront, 
and pain that they experienced. The use of de-identified data to advance future scientific 
research, such as that gathered by the Nazis during torturous hypothermia experiments, has 
also been controversial.
46
 
On the other end of the spectrum is a third type of application that involves using 
data, biospecimens, or other artifacts for education about the unethical event itself. For 
example, museums like the one at Auschwitz-Birkenau display collections of shoes, personal 
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possessions, and art to ―bear testimony‖ to the atrocities that occurred there.47 Similarly, in 
2011, the Bioethics Commission released its ―Subject Data Spreadsheet‖ of the de-identified 
medical and experimental records of the Guatemala STD victims on its website along with its 
report.
6
 These data were released for ethical and educational use to help ―researchers and bio-
ethicists better understand the exploitation of some research subjects in the past to protect the 
contribution of all research participants in the future.‖48 
US Human Subjects Research Regulations  
Despite this agreement regarding use of biological samples derived during the Holocaust, the 
normative debate over appropriate standards of consent for general secondary research use of 
biospecimens is ongoing. In January 2017, the Department of Health and Human Services 
and other major stakeholders released the first comprehensive update to the US human 
subjects research regulations’ ―Common Rule‖ since its codification in 1991.18 These 
revisions grew out of an almost 6-year process, which is still ongoing,
49
 with one of the major 
points of controversy being informed consent to biospecimen research.
20
 
Under the original Common Rule conceptualization, informed consent and 
Institutional Review Board approval are required for federally funded research involving a 
living individual from whom the research obtains data or specimens via ―intervention or 
interaction‖ or ―identifiable private information.‖50 This means that while researchers can 
currently experiment with human biospecimens without consent, as long as they are de-
identified —they cannot do research with data or specimens associated with personal 
identifiers without consent or waiver. The Notice of Proposed Rulemaking (NPRM) for the 
regulatory revisions, which gave interested parties a legally required notice and comment 
opportunity, proposed changing the definition such that research with all biospecimens 
(whether they included ―identifiable private information‖ or not) would trigger informed 
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consent requirements, so as to ―acknowledge and give appropriate weight to this distinct 
autonomy interest in research using biospecimens…‖51(p53942) A previous iteration of this 
notice, the Advance Notice of Proposed Rulemaking (ANPRM), cited the popular nonfiction 
book about secondary research on clinical biospecimens without consent—The Immortal Life 
of Henrietta Lacks—as highlighting these underpinning concerns.52(p44524) The ANPRM had 
originally posed the question of whether existing collections of biospecimens should be 
―grandfathered in‖ so that any new rule requiring consent for all biospecimens would not 
apply to them,
52
 but as the final rule did not require informed consent for de-identified 
biospecimens, the question became moot.
18
 
 In addition to these debates in federal law, US case law protecting human 
biospecimens is scarce and is largely focused on the property interests such specimens might 
represent rather than the privacy and dignitary harms at the forefront of current debate.
53-55
 
Empirical data have demonstrated that while research participants are willing to donate 
biospecimens and data, there is disagreement over how much control donors should retain 
over the specific purposes for which their donations are used.
56
 
Moving Forward 
Curators of contemporary biorepositories are grappling with the challenge of responding in 
ethically appropriate ways to these evolving normative public and professional standards.
57
 
On one hand, many commentators critiquing the proposed revisions to the Common Rule 
noted major practical limitations and great losses to the research community if biospecimens 
were required to be destroyed retroactively.
18
 On the other hand, indefinitely archiving 
human biospecimens collected under egregious circumstances such as the Tuskegee and 
Guatemala experiments raises other concerns. 
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 As was the case for the Nazi medical experiments, the consensus is that—under 
professional research norms at the time of collection—material gathered during the 
Guatemala and Tuskegee experiments was done so unethically.
 4(p86),19 
These experiments 
were a gross violation of the subjects’ autonomy interests as well as social justice 
considerations and caused profound and indefinite harm that continues to engender anger, 
fear, and mistrust.
58-59
 
 Whether or not the Guatemala or Tuskegee biospecimens still exist in government 
archives is not a matter of public knowledge, although it appears likely that they do. For 
example, in 2008, the senior advisor for laboratory science for the Coordinating Center for 
Infectious Diseases at the CDC testified before the US House of Representatives that the 
CDC’s archived biospecimens are only destroyed in ―extremely rare circumstances,‖ such as 
―when required by an Institutional Review Board.‖60 The majority of CDC laboratories have 
no uniform destruction protocols in place, although destruction occurs only ―after study and 
consultation and in a very controlled and documented manner.‖60 In addition, after a vial of 
live smallpox virus was found in an unsecure storage room at the NIH in July 2014,
61
 all US 
government departments and agencies that work with infectious agents were urged to conduct 
a ―safety stand-down‖ to ensure laboratory safety practices.62 As part of this procedure, the 
CDC searched 1,000 of its own laboratory rooms and inventoried and documented over 8 
million stored samples.
62
  
However, an initial search requested by the authors
63
 and conducted by the CDC’s 
Agency for Toxic Substances and Disease Registry, failed to turn up any record regarding 
biospecimens collected during the Tuskegee or Guatemala studies—or even any documents 
that apply to the ―reevaluation, review, retention, or destruction‖ of any such specimens.64 
Given the plethora of public government documentation available regarding PHS 
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involvement in both studies and the retention and discussion of the specimens they 
generated,
4,17,19
 a more thorough public accounting of whether or not these biospecimens are 
still in the possession of the US government as well as their current location is warranted. If 
these biospecimens still exist, they should be retired from the government’s biorepositories 
and their disposition determined by independent stakeholders—including representatives of 
the communities from which they were derived. As was the case for the Nazi medical 
experiment specimens, destruction is one possibility. Another option is donation to a museum 
to represent the physical remains and sacrifices of the victims, much like the human hair on 
display at the Auschwitz-Birkenau Museum.
47
 
 One counterargument to this call for retiring the specimens is that access for 
secondary research use honors the victims. ―The suffering is done—let someone benefit from 
all the pain,‖ argued Lucien A. Ballin, who helped publicize data from Nazi hypothermia 
experiments at the Dachau concentration camp.
65
 However, we believe that this line of 
reasoning—while perhaps appropriate for anonymous data66 or research ethics pedagogy48—
does not apply to biospecimens (either identified or de-identified) in research biorepositories. 
It became clear in the recent debate over the human subjects research regulations that some 
members of the public believe that de-identified biospecimens have a different normative 
value than does data. People ascribe a higher sense of identity and ownership to biospecimens 
that is ethically compelling on the basis of respect for persons as well as encouraging trust in 
the research enterprise. Moreover, while the US Bioethics Commission did not release any 
identifying information about victims of the Guatemala experiments, the government of 
Guatemala released identified medical information and some photographs.
9-11
 Therefore, 
victims have been identified. 
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Ultimately, the federal government declined to regulate research with de-identified 
human biospecimens as some advocates had demanded. Whether or not this was the correct 
balance to strike between the protection of participant autonomy and public beneficence and 
justice, many parties came away from the compromise disappointed. Retirement of the 
Tuskegee and Guatemala biospecimens would be a worthy response to some of the ongoing 
criticisms of continued research use of biospecimens. It would also constitute a clear 
acknowledgment of the reprehensible nature of the Tuskegee syphilis and Guatemala 
intentional exposure experiments. 
 
Conclusion 
While the Guatemala STD intentional exposure experiments occurred over only a two-year 
period, biospecimens collected during these and the Guatemala diagnostic methodology 
experiments remained part of US research protocols for at least a decade following the 
completion of the original research. These biospecimens, along with the Tuskegee samples, 
became part of a critical federal biorepository of syphilitic blood and tissue used for serology 
research for both public health and lucrative business purposes. Though the appropriate 
research use of biospecimens is still a matter of debate, ethicists have roundly condemned the 
continued use of cadavers and specimens obtained during the Holocaust. We call as well for 
the retirement of any biospecimens collected from the Guatemala and Tuskegee experiments 
still in existence in federal biorepositories today. 
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Table 1: Key Players in the Biospecimen Experiments
a
 
Name Affiliation 
Cutler, John C. Director, Guatemala STD Experiments 
Senior Surgeon, Venereal Disease Research Laboratory (VDRL), US 
Public Health Services (PHS) 
Funes, Juan M. Chief, Venereal Disease Section, National Department of Health, 
Guatemala Ministry of Public Health 
Special Consultant with the Venereal Disease Division, Bureau of 
State Services, PHS (1948-1956) 
Levitan, Sacha Assistant Director, Guatemala STD experiments 
Senior Surgeon, PHS 
Magnuson, Harold 
J. 
Director, University of North Carolina (UNC), Venereal Disease 
Experimental Laboratory (VDEL) 
Mahoney, John F. Member, Syphilis Study Section (which recommended the Guatemala 
experiments for approval)  
Principal Investigator, Research Grant-65 for the Prophylaxis and 
Treatment of Gonorrhea and Syphilis (ie, the Guatemala STD 
experiments grant) 
Director, VDRL (1929-1949)  
Olansky, Sidney Senior Surgeon, Director, PHS 
Director, Tuskegee syphilis study (1950-57) 
Salvado, Carlos Director, Guatemala National Psychiatric Hospital 
Special Consultant with the Venereal Disease Division, Bureau of 
State Services, PHS (Dec. 1948-May 1950) 
Stout, Genevieve Serologist, PHS 
Director, Venereal Disease Laboratory and Training Center, 
Guatemala City, Guatemala (Aug. 1948- Aug. 1951) 
Thayer, James D. Chief, UNC VDEL 
a
Adapted from: Bioethics Commission. “Ethically Impossible”: STD Research in Guatemala 
from 1946 to 1948. Washington, D.C.: Government Printing Office; 2011. 
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Figure 1. Photo of Syphilitic Chancre on Arm of Female Psychiatric Patient and Subject of 
the Biospecimen Experiments 
 
Photo of syphilitic chancre (dated 12.30.47) on right arm of female psychiatric patient 0341 
after exposure to syphilis via injection during the intentional exposure experiments (public 
domain);
22
 related clinical notes state she was ―freed‖ in December of 1949; a sample of her 
skin was later requested for the biospecimen experiments (Table 2).  
Figure 2.  Portrait of Male Psychiatric Patient and Subject of the Biospecimen Experiments 
 
Portrait of male psychiatric patient 0432
11(p228)
 (public domain); he was exposed to syphilis 8 
times via the contact method and injection over the period of a year during the intentional 
exposure experiments; a sample of his skin was later requested for the biospecimen 
experiments. 
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Table 2. Key Players in the Guatemala Biospecimen Experiments 
PCSB
I ID
b
 
Cutle
r ID 
Biospecime
n Type 
Se
x 
Dates of 
Intervention(
s) 
STD 
Exposure 
STD Test Treatmen
t 
Notes 
n/s
b
-
0889 
A-
4789 
Cervix F June 4, 1948 Gonorrhea 
via deep 
inoculation
d
 
Positive 
for 
gonorrhea 
None 
recorded 
 
October 6, 
1948 
   ―Died and 
autopsied‖ 
PP
e
-
0059 
A-
4785 
Urethra M August 2, 
1948 
Gonorrhea 
via deep 
inoculation 
 None 
recorded 
 
August 3, 
1948 
  ―Died‖ 
August 4, 
1948 
 Positive 
for 
gonorrhea 
(post-
mortem) 
 
PP-
0075 
A-
4782 
Urethra M March 19, 
1948 
Syphilis via 
scarification 
of the penis
f
 
Negative None 
recorded 
 
June 4, 1948  Gonorrhea 
via deep 
inoculation 
Positive 
for 
gonorrhea 
 
June 12, 1948   ―Patient 
died, 
autopsy 
performed
‖ 
PP – 
0164 
A-
4780 
Skin F October 10, 
1948 
Chancroid via 
scarification 
on left arm 
 None 
recorded 
 
October 11, 
1948 
Chancroid via 
scarification 
on right arm 
 ―Sites 
inoculated 
on 10/10 
showed 
nothing‖ 
October 12, 
1948 
Chancroid via 
scarification 
on right arm 
 ―No results 
from 
inoculation
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―using 
material 
taken 
from…patient
‖ 
s on 10/10 
or 10/11‖ 
October 22, 
1948 
 Positive 
for 
chancroid 
 
October 23, 
1948 
  ―Died‖ 
PP-
0211 
A-
4783 
Urethra and 
cervix 
F February 2, 
1948 
Intracutaneou
s injection of 
syphilis 
 None 
recorded 
None 
June, 1948 Gonorrhea 
via deep 
inoculation 
with material 
taken from 
another 
psychiatric 
patient 
  
July 3-8, 1948  Positive 
for 
gonorrhea 
in both 
eyes, 
urethra, 
and 
―meatus‖ 
PP-
0341 
S-
3216 
Skin F November 30, 
1947 
Syphilis via 
intracutaneou
s injection 
into right arm 
Positive 
for 
syphilis 
  
December 5, 
1947 
 No 
clinical 
evidence 
of syphilis 
  
January 11, 
1948 
Chancre from 
her arm used 
to produce 
serum used in 
another 
syphilis 
experiment 
Chancres   
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March 1, 1948   Treatment 
with 
penicillin 
 
December 12, 
1949 
   Freed  
PP-
0432 
S-
3218 
Skin M May 13, 1947 Exposed to 
syphilis via 
contact 
method
g
 four 
times, and 
injection into 
right forearm 
   
June 13, 1947 Exposed to 
syphilis via 
contact 
method and 
―subcutaneou
s method‖h 
Conflictin
g data for 
syphilis 
test 
  
June 18, 1947    ―Biopsy 
taken and 
sent to 
Dr.Sofian 
at USMH, 
S.I.
i
 
July 19, 1947   Treatment 
with 
penicillin 
 
 
May 9, 1948 Injection of 
syphilis into 
left forearm 
   
June 23, 1948   Treatment 
with 
penicillin  
 
July 7, 1948 
and October 
18, 1949 
 Spinal tap   
PP-
0438 
A-
4784 
Urethra M 
(45 
yrs
) 
January 11, 
1948 
Exposure to 
syphilis via 
scarrification 
of penis, six 
applications 
of pledgets, 
removed after 
None 
recorded  
None 
recorded 
Epileptic 
patient  
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2 hours 
February 25, 
1948 
 Died and 
autopsy 
performed 
a. Adapted from the Presidential Commission for the Study of Bioethical Issues, 
Guatemala Subject Data Spreadsheet.
6
  
b. PCSBI = Presidential Commission for the Study of Bioethical Issues. 
c. The Bioethics Commission had been unable to categorize the subject population of 
this subject in its own empirical analysis, but given her inclusion in the biospecimen 
set, we concluded she must have been a psychiatric patient. 
d. In the deep inoculation method a toothpick was moistened with pus from an ―acute 
case of gonorrhea in the male‖ and then ―the toothpick swab was...inserted about ½ 
[inch] into the urethra, and carefully rubbed over the mucous membrane, so much so 
as to cause pain.‖ PCSBI. “Ethically Impossible”: STD Research in Guatemala from 
1946 to 1948. Washington, D.C.: Government Printing Office; 2011, 48-49. 
e. PP = Psychiatric Patent. 
f. In the scarification method researchers abraded the penis of the subject so as to break 
the skin and then applied a pledget soaked in syphilitic material to the injured area. 
PCSBI. “Ethically Impossible”: STD Research in Guatemala from 1946 to 1948. 
Washington, D.C.: Government Printing Office; 2011, 62. 
g. In the ―contact method‖ a ―cotton pledget was placed at the frenum [of the penis] 
and moistened with varying amounts of suspension and at intervals…The foreskin 
was replaced to normal position concealing the pledget entirely.‖ PCSBI. “Ethically 
Impossible”: STD Research in Guatemala from 1946 to 1948. Washington, D.C.: 
Government Printing Office; 2011, 61. 
h. ―Subcutaneous method‖ likely means injection. 
i. Dr. L. Sofian at the United States Marine Hospital, Staten Island. 
 
 
 
 
 
 
